|
I came across ARNX about a month ago and have watched it reach above $6 on news that they were expanding phase I trials on their HIV drug. It seems that this drug is tolerated well and could be a great hit. I recently had a lecture by one of the scientists involved in developing the now famous protease inhibitors, it seems like this would be the perfect complement to the now available drugs if it does indeed have any positive effect. ARNX also has other products being tested and now have plenty of cash after having completed an offering of 6mil shares at $5. Looks promising to me. Anyone know how the trial is going? |
